EDITORIAL
Year : 2016  |  Volume : 1  |  Issue : 4  |  Page : 1-5

The “Chinese Dose” of statin


Department of Geriatric, Chinese PLA General Hospital, Beijing, China

Correspondence Address:
Prof. Ping Ye
Department of Geriatric, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, 100853 Beijing
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2470-7511.248366

Get Permissions

The benefits of atherosclerotic cardiovascular disease prevention/treatment and lipid-lowering therapy come from the reduction of cholesterol itself. However, based on safety considerations, all guidelines note that high-intensity statin therapy is not suitable for the Asian/Chinese population. Therefore, moderate-intensity statin therapy is more beneficial for the Chinese population. However, for some very high-risk patients when moderate-intensity statin cannot satisfy the lipid-lowering needs, statin combination with ezetimibe is an ideal choice.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2723    
    Printed258    
    Emailed0    
    PDF Downloaded224    
    Comments [Add]    
    Cited by others 2    

Recommend this journal